243 related articles for article (PubMed ID: 2472812)
1. MS: a localized immune disease of the central nervous system.
Calder V; Owen S; Watson C; Feldmann M; Davison A
Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
[TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Martin R; McFarland HF
Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
4. Initiation and regulation of CNS autoimmunity.
Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
[TBL] [Abstract][Full Text] [Related]
5. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
6. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
Béraud-Juven E
Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
8. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.
Cross AH; Cannella B; Brosnan CF; Raine CS
Lab Invest; 1990 Aug; 63(2):162-70. PubMed ID: 1696331
[TBL] [Abstract][Full Text] [Related]
9. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
11. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
[No Abstract] [Full Text] [Related]
12. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
Seil FJ; Agrawal HC
Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
[No Abstract] [Full Text] [Related]
13. Intravenous antigen administration as a therapy for autoimmune demyelinating disease.
Racke MK; Critchfield JM; Quigley L; Cannella B; Raine CS; McFarland HF; Lenardo MJ
Ann Neurol; 1996 Jan; 39(1):46-56. PubMed ID: 8572666
[TBL] [Abstract][Full Text] [Related]
14. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
Stuerzebecher S; Martin R
Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
Raine CS
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
[No Abstract] [Full Text] [Related]
17. B cells in spontaneous autoimmune diseases of the central nervous system.
Berer K; Wekerle H; Krishnamoorthy G
Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
[TBL] [Abstract][Full Text] [Related]
18. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
De Santi L; Annunziata P; Sessa E; Bramanti P
J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
[TBL] [Abstract][Full Text] [Related]
20. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
